Fineline Cube

Follow:
14483 Articles
Gan & Lee Pharmaceuticals Initiates Phase I Clinical Trial for Biosimilar Secukinumab
CompanyDrug

Gan & Lee Pharmaceuticals Initiates Phase I Clinical Trial for Biosimilar Secukinumab

Lundbeck’s Vyepti Migraine Treatment Available at Sun Yat-sen Memorial Hospital Through Greater Bay Area Policy
CompanyDrug

Lundbeck’s Vyepti Migraine Treatment Available at Sun Yat-sen Memorial Hospital Through Greater Bay Area Policy

Lee’s Pharmaceutical’s Subsidiary Reports Positive Results from Phase III Myopia Treatment Study
CompanyDrug

Lee’s Pharmaceutical’s Subsidiary Reports Positive Results from Phase III Myopia Treatment Study

NMPA's Center for Drug Evaluation Issues New Guidelines for Domestic Transfer of Overseas-Produced Vaccines
Policy / Regulatory

NMPA’s Center for Drug Evaluation Issues New Guidelines for Domestic Transfer of Overseas-Produced Vaccines

CompanyDeals

Eccogene Inc. Secures $60 Million Milestone Payment from AstraZeneca for ECC5004/AZD5004

Sunshine Guojian Pharma Reports Q3 Revenue Growth and Advances in Clinical Trials
Company

Sunshine Guojian Pharma Reports Q3 Revenue Growth and Advances in Clinical Trials

LINDIS Biotech's Catumaxomab Receives Positive Opinion from EMA's COMP for Malignant Ascites Treatment
CompanyDrug

LINDIS Biotech’s Catumaxomab Receives Positive Opinion from EMA’s COMP for Malignant Ascites Treatment

China's NMPA Launches Pilot Program for Phased Manufacturing of Biological Products
Policy / Regulatory

China’s NMPA Launches Pilot Program for Phased Manufacturing of Biological Products

Beijing Biostar Technologies Goes Public in Hong Kong to Fund Cancer Drug Development
CompanyDeals

Beijing Biostar Technologies Goes Public in Hong Kong to Fund Cancer Drug Development

China Grand Pharmaceutical Receives NMPA Approval for Innovative Adjustable Thrombectomy Stent
CompanyMedical Device

China Grand Pharmaceutical Receives NMPA Approval for Innovative Adjustable Thrombectomy Stent

Grifols Partners with BARDA to Develop Treatment for Sulfur Mustard Ocular Injury
CompanyDeals

Grifols Partners with BARDA to Develop Treatment for Sulfur Mustard Ocular Injury

Hunan Province Launches Pilot Program for Retail Sales of VBP Drugs with Strict Guidelines
Policy / Regulatory

Hunan Province Launches Pilot Program for Retail Sales of VBP Drugs with Strict Guidelines